Tilray, Inc. (TLRY) financial statements (2021 and earlier)

Company profile

Business Address 1100 MAUGHAN ROAD
NANAIMO, BC V9X 1J2
State of Incorp. DE
Fiscal Year End December 31
SIC 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments97518
Cash and cash equivalents97487
Short-term investments 30
Receivables117
Inventory, net of allowances, customer advances and progress billings8816
Inventory8816
Prepaid expense6 
Deposits current assets25 
Other undisclosed current assets424
Total current assets:259554
Noncurrent Assets
Operating lease, right-of-use asset18
Property, plant and equipment18480
Long-term investments and receivables11 
Long-term investments11 
Intangible assets, net (including goodwill)3924
Goodwill163 
Intangible assets, net (excluding goodwill)2294
Deposits noncurrent assets 1
Other undisclosed noncurrent assets3217
Total noncurrent assets:637102
TOTAL ASSETS:896657
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8811
Accounts payable3911
Accrued liabilities18 
Employee-related liabilities25 
Interest and dividends payable6 
Debt20
Business combination, contingent consideration, liability0 
Other undisclosed current liabilities215
Total current liabilities:9226
Noncurrent Liabilities
Long-term debt and lease obligation460429
Long-term debt, excluding current maturities430420
Finance lease, liability14
Capital lease obligations8
Operating lease, liability15
Liabilities, other than long-term debt04
Deferred tax liabilities, net4
Other liabilities0 
Other undisclosed noncurrent liabilities59 
Total noncurrent liabilities:519433
Total liabilities:611459
Stockholders' equity
Stockholders' equity attributable to parent, including:285198
Additional paid in capital706302
Accumulated other comprehensive income104
Accumulated deficit(430)(108)
Other undisclosed stockholders' equity attributable to parent00
Total stockholders' equity:285198
TOTAL LIABILITIES AND EQUITY:896657

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
Revenues15443
Cost of revenue(13)(29)
Cost of goods and services sold(13)(0)
Other undisclosed gross profit(164) 
Gross profit:(23)14
Operating expenses(289)(51)
Other undisclosed operating income (loss)11(21)
Operating loss:(302)(58)
Nonoperating income (expense)9(5)
Foreign currency transaction gain (loss), before tax6(7)
Other nonoperating income32
Interest and debt expense(0)(6)
Loss from continuing operations before equity method investments, income taxes:(293)(69)
Other undisclosed loss from continuing operations before income taxes(37)(3)
Loss from continuing operations before income taxes:(330)(72)
Income tax expense (benefit)8(0)
Net loss:(321)(72)
Other undisclosed net income attributable to parent 4
Net loss attributable to parent:(321)(68)
Preferred stock dividends and other adjustments (0)
Net loss available to common stockholders, diluted:(321)(68)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
Net loss:(321)(72)
Comprehensive loss:(321)(72)
Other undisclosed comprehensive income, net of tax, attributable to parent54
Comprehensive loss, net of tax, attributable to parent:(316)(68)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: